SL Hauser, BAC Cree - The American journal of medicine, 2020 - Elsevier
Multiple sclerosis (MS) is an autoimmune demyelinating and neurodegenerative disease of the central nervous system, and the leading cause of nontraumatic neurological disability in …
C Walton, R King, L Rechtman, W Kaye… - Multiple Sclerosis …, 2020 - journals.sagepub.com
Background: High-quality epidemiologic data worldwide are needed to improve our understanding of disease risk, support health policy to meet the diverse needs of people …
Importance Emergence of SARS-CoV-2 causing COVID-19 prompted the need to gather information on clinical outcomes and risk factors associated with morbidity and mortality in …
Multiple sclerosis (MS) is a neuro-inflammatory and neurodegenerative disease that is most prevalent in Northern Europe. Although it is known that inherited risk for MS is located within …
J Lo, L Chan, S Flynn - Archives of physical medicine and rehabilitation, 2021 - Elsevier
Objectives To present recent evidence on the prevalence, incidence, costs, activity limitations, and work limitations of common conditions requiring rehabilitation. Data Sources …
Background Dysregulation of gut microbiota-associated tryptophan metabolism has been observed in patients with multiple sclerosis. However, defining direct mechanistic links …
M Ward, MD Goldman - CONTINUUM: Lifelong Learning in …, 2022 - journals.lww.com
Epidemiology and Pathophysiology of Multiple Sclerosis : CONTINUUM: Lifelong Learning in Neurology Account Register Activate Subscription Help Subscribe American Academy of …
B Bebo, I Cintina, N LaRocca, L Ritter, B Talente… - Neurology, 2022 - AAN Enterprises
Background and Objectives A recent report estimated that approximately 1 million adults were living with multiple sclerosis (MS) in the United States. Although MS is rarely the direct …
JH Yang, T Rempe, N Whitmire, A Dunn-Pirio… - Frontiers in …, 2022 - frontiersin.org
Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system that causes significant disability and healthcare burden. The treatment of MS has evolved over …